Structure Therapeutics Q3 EPS $(0.20), Inline
Structure Therapeutics Q3 EPS $(0.20), Inline
Structure Therapeutics第三季度每股收益爲$(0.20),與預期一致
Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.20) per share which met the analyst consensus estimate. This is a 4.76 percent increase over losses of $(0.21) per share from the same period last year.
Structure Therapeutics(納斯達克:GPCR)報告季度虧損爲每股$(0.20),符合分析師一致預期。這比去年同期每股虧損$(0.21)增長了4.76%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。